BERGEM·HEALTH
Free consultation
Home › Treatments › Gastroenterology
SPECIALITY · GASTROENTEROLOGY

Gastroenterology in Türkiye — hepatitis C cure, IBD biologics, advanced endoscopy

Direct-acting antivirals for HCV (SVR12 >95%), biologic therapy for Crohn’s/UC, therapeutic endoscopy (ESD, EUS, ERCP), hepatology with transplant pathway.

What you get
  • Written second opinion on endoscopy, biopsy, FibroScan in 48 hours
  • Hepatitis C cure with DAA — 8–12 week courses, SVR12 >95%
  • IBD pathway: infusion centre, fast-track flare protocols
  • End-stage liver disease referred to organ-transplant team
5 hospitals · 9 GI professors · DAA · ESD · EUS-FNA · FibroScan
SECOND OPINION ONLINE

Second opinion from a GI/hepatology professor — within 48 hours, free

Send your endoscopy report, biopsy, FibroScan, viral load or recent imaging — the professor returns a written second opinion within 48 hours, free of charge.

01
Upload your discharge summary
Discharge summaries, CT/MRI discs (DICOM), histology slides if available. Up to 200 MB.
02
Coordinator reviews
Selects 2–3 professors matched to your diagnosis and stage. Sends them your records.
03
Video consultation
The professor responds online — review of histology, protocol, travel plan if needed.
What to send
  • Discharge summaries from inpatient / outpatient care
  • CT or MRI — original DICOM discs
  • Histology report (if available)
  • Slides or blocks for review (optional)
  • Current therapy list
Request a second opinion
Free. Confidential. Anna Moroz reads every request personally.
10 PROCEDURES

What we treat in gastroenterology

Liver disease, IBD, oncology workup and advanced endoscopy across JCI hospitals in Istanbul and Antalya.

TREATMENT METHODS

Treatment methods in gastroenterology

DAA antivirals, biologics, advanced therapeutic endoscopy (ESD/EUS/ERCP), interventional radiology for portal hypertension.

Direct-acting antivirals (DAA) for HCV
Sofosbuvir/velpatasvir, glecaprevir/pibrentasvir. 8–12 week courses.
5 clinics
Biologic therapy for IBD
Infusion centre with infliximab, vedolizumab, JAK inhibitors.
4 clinics
Endoscopic Submucosal Dissection (ESD)
Curative resection of early GI cancer.
3 clinics
Endoscopic Ultrasound (EUS)
Diagnostic + therapeutic — EUS-FNA, EUS-BD.
3 clinics
ERCP
Bile and pancreatic duct intervention, stenting.
4 clinics
Radiofrequency ablation of Barrett’s
Endoscopic dysplasia eradication.
2 clinics
TIPS
Transjugular intrahepatic portosystemic shunt.
2 clinics
Bariatric endoscopy
ESG, intragastric balloon for selected patients.
3 clinics
GASTROENTEROLOGY · TEAM

Professors you get direct access to

Department heads at JCI hospitals in Türkiye. Direct contact, no middlemen.

Prof. Dr. Bülent Yıldırım, MD
Professor of Internal Medicine, Head of Gastroenterology
Akdeniz University Hospital
Prof. Dr. Eylem Karatay, MD
Professor of Gastroenterology
Liv Hospital Vadistanbul
Prof. Dr. Erdem Koçak, MD
Professor of Gastroenterology
Liv Hospital Vadistanbul
Prof. Dr. İrfan Koruk, MD
Professor of Gastroenterology
Liv Hospital Ulus
Prof. Dr. Binnur Pınarbaşı, MD
Professor of Gastroenterology
Liv Hospital Ulus
Prof. MD. Altay Kandemir
Professor of Gastroenterology
Liv Hospital Ulus
Prof. Dr. Yusuf Ziya Erzin, MD
Professor of Gastroenterology
Memorial Bahu00e7elievler Hospital | Istanbul University-Cerrahpau015fa
Prof. Dr. Salih Boğa, MD
Professor of Gastroenterology and Hepatology
Memorial Bahu00e7elievler Hospital
Prof. Dr. A. Emre Yıldırım, MD
Professor of Gastroenterology and Hepatology
Memorial Bahu00e7elievler Hospital
CLINICS

Clinics where treatment takes place

JCI-accredited hospitals with specialised departments and end-to-end support.

JCI GOLD SEAL
Akdeniz University Hospital

Крупнейшая университетская клиника средиземноморского региона Турции. 1 267 коек, 29 операционных, 43 клинических отделения. Мировой лидер в трансплантации — первая…

Learn more about the clinic
JCI GOLD SEAL
Liv Hospital Vadistanbul

Новейшая «умная» клиника группы Liv Hospital в комплексе Vadistanbul. JCI и TÜV SÜD, 125 коек, 7 операционных, палаты с видом…

Learn more about the clinic
JCI GOLD SEAL
Liv Hospital Ulus

Флагманская клиника группы Liv Hospital в престижном районе Улус. JCI-аккредитация, первый сертификат SRC по роботизированной хирургии за пределами США, 154…

Learn more about the clinic
JCI GOLD SEAL
Memorial Bahçelievler Hospital

Крупнейшая клиника Memorial Health Group в Стамбуле. Первая полноценная клиника в мире с LEED Platinum. 320 коек, 15 операционных (включая…

Learn more about the clinic
JCI GOLD SEAL
Memorial Antalya Hospital

JCI-аккредитованная клиника группы Memorial Health Group в Анталье. Лауреат European Healthcare Awards 2021 как лучшая частная клиника Турции. 132 койки,…

Learn more about the clinic
DIAGNOSTICS

GI diagnostics

Gastroscopy, colonoscopy, EUS, FibroScan, viral load, MRI — completed within 1–3 days at a single hospital.

Gastroscopy (EGD)
Upper GI inspection with biopsy.
30 min
Colonoscopy with chromoendoscopy
Polyp detection and biopsy.
45 min
Endoscopic ultrasound (EUS)
Pancreatic, biliary, gastric staging.
1 hour
FibroScan (transient elastography)
Non-invasive liver fibrosis assessment.
15 min
Liver MRI 3T with hepatospecific contrast
HCC characterisation.
1 day
24-hour pH impedance
GERD diagnosis.
24 h
Hydrogen breath test
SIBO, lactose, fructose intolerance.
3 hours
HCV/HBV viral load + genotype
Confirms eligibility for therapy.
1 day
PRICE SNAPSHOT

GI procedures pricing — Türkiye vs EU/USA

Final cost is determined by the medical board after reviewing documents. Prices are indicative.

Procedure Türkiye EU / USA Savings
Hepatitis C cure (12-week DAA) $3 500 – 5 500 $20 000 – 60 000 −85%
Colonoscopy + biopsy $400 – 700 $2 000 – 4 000 −80%
Gastroscopy + biopsy $300 – 550 $1 500 – 3 000 −80%
ESD (early GI cancer) $4 500 – 7 500 $20 000 – 40 000 −75%
ERCP with stenting $3 000 – 5 000 $10 000 – 22 000 −70%
Biologic infusion (per infliximab cycle) $800 – 1 500 $3 000 – 6 000 −70%
TIPS $9 000 – 14 000 $30 000 – 55 000 −70%
FibroScan $80 – 150 $300 – 600 −70%
The information on this page is for reference only and does not constitute a medical opinion.
Request a precise quote for my case
QUESTIONS

Frequently asked about Gastroenterology

Can hepatitis C really be cured?
Yes — SVR12 (sustained virological response at 12 weeks) exceeds 95% with modern DAA regimens. 8 weeks for treatment-naïve without cirrhosis, 12 weeks otherwise. We monitor virological response after treatment.
IBD: when do I need biologics?
Moderate-to-severe disease, steroid-dependent or steroid-refractory, or extensive disease at diagnosis. Anti-TNF (infliximab/adalimumab) is first-line; vedolizumab if extra-intestinal manifestations.
Early stomach cancer — surgery or ESD?
If T1a (mucosal), well-differentiated, <2 cm and without ulceration — ESD is curative and avoids gastrectomy. Multidisciplinary team confirms staging.
Liver transplant — when is it considered?
MELD ≥15, decompensation, or HCC within Milan criteria. We refer to our hepatobiliary and transplant surgery team — see Organ transplantation.
Am I a candidate for endoscopic submucosal dissection (ESD) for early colorectal cancer?
ESD is offered for well/moderately differentiated T1a lesions under 30 mm without lymphovascular invasion, confirmed by magnifying NBI and EUS. En-bloc R0 resection rates in our JCI-accredited endoscopy units exceed 92%, with 5-year disease-free survival above 95%. Follow-up colonoscopy at 3, 6 and 12 months is standard, then annually.
Should I have capsule endoscopy or colonoscopy for suspected IBD or obscure GI bleeding?
Colonoscopy with ileoscopy and biopsies remains first-line for diagnosing Crohn's or ulcerative colitis. Capsule endoscopy (PillCam SB3) is added when small-bowel disease or obscure bleeding is suspected after negative upper/lower scopes, with diagnostic yield around 60-70%. A patency capsule is used first if stricture risk exists, and findings are correlated by an MDT within 7-10 days.
How is NAFLD/MASLD diagnosed and treated in 2026?
Diagnosis combines liver enzymes, FIB-4, and FibroScan (CAP for steatosis, kPa for fibrosis); biopsy is reserved for indeterminate F2-F3 cases. First-line treatment is 7-10% weight loss, GLP-1 agonists if BMI >30 or T2D, and resmetirom (Rezdiffra, FDA-approved March 2024) for biopsy-proven F2-F3 MASH. Patients are reassessed at 3 and 6 months by a hepatology MDT.
REQUEST

Tell me about your case — I’ll read it personally.

Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.

Open the consultation form
  • Reply within 4 hours during business hours
  • Confidentiality guaranteed
  • Coordinator-translator inside the doctor’s office
  • Tumour board of 2–3 professors within 72 hours